Valuation: MiniMed Group, Inc.

Market Cap 6.3B 5.49B 5.2B 4.72B 8.81B 605B 8.86B 61.86B 23.91B 307B 23.67B 23.14B 983B P/E 2027 *
37.2x
P/E 2028 * 29.9x
Enterprise Value 6.01B 5.23B 4.95B 4.5B 8.4B 576B 8.45B 58.95B 22.78B 292B 22.55B 22.05B 936B EV / Sales 2027 *
1.75x
EV / Sales 2028 * 1.53x
Free-Float
10.08%
Yield 2027 *
-
Yield 2028 * -
1 day-1.65%
1 week-3.21%
Current month+8.74%
1 month+9.33%
3 months+49.86%
6 months+38.03%
1 week 21.27
Extreme 21.27
23.74
1 month 18.85
Extreme 18.85
24.43
Current year 10.65
Extreme 10.65
24.43
1 year 10.65
Extreme 10.65
24.43
3 years 10.65
Extreme 10.65
24.43
5 years 10.65
Extreme 10.65
24.43
10 years 10.65
Extreme 10.65
24.43
Date Insider Type Main position Quantity % Market Cap. Importance
7/31/26 Tax

Chief Executive Officer

-31,350 0.0112%
7/31/26 Tax

Chief Technology Officer

-8,012 0.0029%
7/31/26 Tax

General Counsel

-1,762 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
-1.65%-3.21% - - 6.3B
+0.15%-0.22%+21.26%+19.16% 12.54B
-0.62%+0.25%+12.97%+19.11% 6.69B
+0.34%+0.64%+23.73%+10.51% 5.6B
+0.37%+1.89%-18.21%+38.13% 5.04B
+0.73%+1.56%-33.36%-24.76% 3.85B
+3.08%+6.97%+31.86%-13.37% 1.89B
+0.17%+1.34%+0.66%+185.18% 1.75B
+0.49%-0.16%+48.26%-16.10% 1.61B
+3.99%+1.26%-17.29%+37.96% 1.33B
Average +0.70%+0.43%+7.77%+28.43% 4.66B
Weighted average by Cap. +0.13%+0.24%+9.48%+21.04%

Financials

2027 *2028 *
Net sales 3.44B 2.99B 2.83B 2.57B 4.81B 330B 4.83B 33.74B 13.04B 167B 12.91B 12.62B 536B 3.72B 3.24B 3.07B 2.79B 5.2B 357B 5.23B 36.52B 14.12B 181B 13.97B 13.66B 580B
Net income 171M 149M 141M 128M 239M 16.39B 240M 1.68B 648M 8.31B 642M 628M 26.64B 251M 219M 207M 188M 351M 24.08B 353M 2.46B 953M 12.21B 943M 922M 39.14B
Net Debt -297M -259M -245M -222M -415M -28.49B -418M -2.92B -1.13B -14.45B -1.12B -1.09B -46.31B -600M -523M -495M -449M -839M -57.57B -844M -5.89B -2.28B -29.2B -2.25B -2.2B -93.57B
Logo MiniMed Group, Inc.
MiniMed Group, Inc. is a medical technology company, which develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Its fully integrated system addresses pain points for people with diabetes (PWD): health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system. The MiniMed 780G system uses its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings. The MiniMed 780G consists of the MiniMed 780G insulin pump, the Simplera Sync CGM sensor, and the instinct sensor. Its platform of clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and a Smart Multiple Daily Injection (MDI) System. Its pipeline products are the MiniMed Flex, screenless insulin pump, next-generation Vivera dosing algorithm, and MiniMed Fit patch pump with extended wear.
Employees
-
Date Price Change Volume
26-09-17 US$22.03 -1.65% 2,730,161
26-09-16 US$22.40 +1.77% 4,068,882
26-09-15 US$22.01 +0.18% 2,127,128
26-09-14 US$21.97 -2.36% 4,386,564
26-09-11 US$22.50 +0.27% 1,423,592
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
22.40USD
Average target price
24.55USD
Spread / Average Target
+9.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MMED Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!